Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology currently manages 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 5 distinct art units, indicating a diverse range of subject matter within the life sciences sector. The involvement of multiple art units suggests that the university's research applications are being evaluated by various specialized groups at the patent office.
The prosecution workload involves 7 distinct examiners, a count that equals the total number of pending office actions. MADELINE MCGUIRE DEKARSKE is identified as the busiest examiner for this portfolio, though she is responsible for only 1 pending office action. This distribution shows that the pending matters are spread evenly across the assigned patent office personnel rather than being concentrated under a single individual. Because the number of examiners matches the number of actions, each official is currently managing a single matter for the institution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| HANEY, AMANDA MARIE | 1 | 36.4% | +44.9% |
| O'NEILL, MARISOL ANN | 1 | 53.1% | +68.2% |
| PAULUS, ERIN VIRGINIA | 1 | 21.1% | +93.8% |
| BAEK, JONGHWAN NMN | 1 | 60.0% | +0.0% |
| MACFARLANE, STACEY NEE | 1 | 53.5% | +39.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18409015 | PREPARATION METHOD AND USE OF HYDROGEL MATERIAL FOR GROWTH OF BLOOD VESSEL ORGANOIDS | O'NEILL, MARISOL ANN | 42d |
| 18889293 | METHOD FOR TREATING CALCIFIC HEART VALVE DISEASE(CHVD) | DEKARSKE, MADELINE MCGUIRE | — |
| 18432678 | METHOD FOR DETECTING CD19 EXPRESSION | HANEY, AMANDA MARIE | — |
| 18527746 | Fluorescently Labeled Lentiviral Vector, And Preparation Methods And Use Thereof | PAULUS, ERIN VIRGINIA | — |
| 18520118 | Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1)-Targeted Nanoprobe For Integrated Diagnosis And Treatment, And Preparation Method And Use Thereof | BAEK, JONGHWAN NMN | — |
| 18459076 | METHOD FOR DETECTING ANTI-CAR ANTIBODY AGAINST HUMANIZED CART CELLS | MACFARLANE, STACEY NEE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18409015 | PREPARATION METHOD AND USE OF HYDROGEL MATERIAL FOR GROWTH OF BLOOD VESSEL ORGANOIDS | O'NEILL, MARISOL ANN | 42d |
| 18432678 | METHOD FOR DETECTING CD19 EXPRESSION | HANEY, AMANDA MARIE | — |
| 18527746 | Fluorescently Labeled Lentiviral Vector, And Preparation Methods And Use Thereof | PAULUS, ERIN VIRGINIA | — |
| 18459076 | METHOD FOR DETECTING ANTI-CAR ANTIBODY AGAINST HUMANIZED CART CELLS | MACFARLANE, STACEY NEE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| 1618 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18889293 | METHOD FOR TREATING CALCIFIC HEART VALVE DISEASE(CHVD) | DEKARSKE, MADELINE MCGUIRE | — | §102§103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18432678 | METHOD FOR DETECTING CD19 EXPRESSION | HANEY, AMANDA MARIE | 1682 | §101§103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18409015 | PREPARATION METHOD AND USE OF HYDROGEL MATERIAL FOR GROWTH OF BLOOD VESSEL ORGANOIDS | O'NEILL, MARISOL ANN | 1633 | §102§103§112 | Non-Final OA | 42d | Pending | Jan 10, 2024 |
| 18527746 | Fluorescently Labeled Lentiviral Vector, And Preparation Methods And Use Thereof | PAULUS, ERIN VIRGINIA | 1631 | §103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18520118 | Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1)-Targeted Nanoprobe For Integrated Diagnosis And Treatment, And Preparation Method And Use Thereof | BAEK, JONGHWAN NMN | 1618 | §103§112 | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18459076 | METHOD FOR DETECTING ANTI-CAR ANTIBODY AGAINST HUMANIZED CART CELLS | MACFARLANE, STACEY NEE | 1675 | §101§103 | Non-Final OA | — | Pending | Aug 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial